greeksoup/ stock research
Stock research / United States / OBIO / Planned sales

Orchestra BioMed Holdings, Inc. planned insider sales

In the last twelve months insiders at Orchestra BioMed Holdings, Inc. filed 5 Form 144 notices of planned sales, 75,000 shares worth $353,491 at the time of filing, from 1 seller. The latest, filed 1 October 2026: Sherman Darren (officer, director), 15,000 shares worth $94,050, planned for around 1 October 2026 through Fidelity Brokerage Services LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
1 October 2026Sherman DarrenOfficer, Director15,000$94,0501 October 202615,000 shares from 1 October 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
1 September 2026Sherman DarrenOfficer, Director15,000$75,3001 September 202615,000 shares from 1 September 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
3 August 2026Sherman DarrenOfficer, Director15,000$61,2923 August 202615,000 shares from 3 August 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
1 July 2026Sherman DarrenOfficer, Director15,000$64,8001 July 202615,000 shares from 1 July 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
1 June 2026Sherman DarrenOfficer, Director15,000$58,0501 June 202615,000 shares from 1 June 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?